hs-CRP — what high-sensitivity C-reactive protein tells you about cardiovascular risk

Paired condition: High cholesterol lab work

Quick answer

hs-CRP (high-sensitivity C-reactive protein) is a blood marker of low-grade, body-wide inflammation. It is not specific to any one disease, but in a cardiovascular-risk context it adds information beyond cholesterol: people with elevated hs-CRP have higher rates of heart attack and stroke even when their LDL looks fine. Because a recent cold, injury, or flare can spike it, hs-CRP is most useful when measured while you're well and confirmed on a repeat draw.

Reference ranges and interpretation

Value / population	Classification	What it means
< 1.0 mg/L	Lower cardiovascular risk	The AHA/CDC low-risk band for CRP used as a cardiovascular risk marker.
1.0 – 3.0 mg/L	Average cardiovascular risk	The intermediate band.
> 3.0 mg/L	Higher cardiovascular risk	Higher-risk band — recheck when well; persistent elevation is the meaningful signal.
> 10 mg/L	Likely acute inflammation, not baseline risk	Usually reflects infection, injury, or a flare. Retest in ~2 weeks once recovered before interpreting as cardiovascular risk.

These bands (from the 2003 AHA/CDC statement) apply to hs-CRP used as a cardiovascular risk marker in people without acute illness. Standard (non-high-sensitivity) CRP is a different clinical test used to track active infection or autoimmune disease and uses different thresholds.

What hs-CRP measures — and what it doesn't

CRP is a protein the liver releases in response to inflammation. The "high-sensitivity" assay can detect the low concentrations that matter for long-term cardiovascular risk, which a standard CRP test rounds off.

What it does well: it flags chronic, low-grade inflammation that contributes to atherosclerosis. In large studies, hs-CRP predicted cardiovascular events independently of LDL cholesterol — meaning two people with the same cholesterol can carry different risk.

What it does not do: it does not tell you where the inflammation is coming from. hs-CRP is a smoke detector, not a diagnosis. A high value warrants looking for a cause (weight/metabolic health, smoking, gum disease, an autoimmune condition, a smoldering infection) rather than assuming it's the heart.

What different values typically indicate

< 1.0 mg/L: the lower-risk band. Common in people who are metabolically healthy, non-smokers, and active.

1.0 – 3.0 mg/L: average risk. Worth pairing with the rest of the cardiovascular picture (LDL, ApoB, blood pressure, glucose).

> 3.0 mg/L (confirmed, while well): higher cardiovascular risk. The JUPITER trial showed that people with LDL under 130 mg/dL but hs-CRP above 2.0 mg/L had meaningfully fewer cardiovascular events when treated with a statin — evidence that this signal is actionable, not just interesting.

> 10 mg/L: almost always acute inflammation (a virus, an injury, a dental infection, an autoimmune flare) rather than baseline cardiovascular risk. Retest once you've recovered before reading anything into it.

What to look at alongside hs-CRP

hs-CRP is one input, not a verdict. The fuller picture includes:

- LDL cholesterol and ApoB — the causal lipids; hs-CRP adds residual risk on top
- Blood pressure — a major independent driver of cardiovascular risk
- HbA1c / fasting glucose / insulin — metabolic health is a leading source of chronic inflammation
- Waist circumference / body composition — visceral fat is metabolically active and pro-inflammatory
- Smoking status — one of the strongest reversible contributors
- A repeat hs-CRP — a single value is easy to misread; the trend when well is the truth

The CANTOS trial later showed that directly lowering inflammation (with an anti-inflammatory drug, no effect on cholesterol) reduced cardiovascular events — biological confirmation that inflammation itself, not just what raises it, is part of the risk.

What temporarily distorts hs-CRP

hs-CRP moves for many reasons that have nothing to do with your heart:

- Recent infection or illness — even a cold can push it up for days to weeks
- Injury, surgery, or intense exercise in the days before the draw
- Active autoimmune disease (e.g., rheumatoid arthritis, lupus) — inflammation from the condition itself
- Obesity — fat tissue raises baseline CRP
- Estrogen / hormone therapy — can modestly raise CRP
- Pregnancy

Because of this, hs-CRP should be measured when you feel well, away from illness or injury, and a single elevated value should be confirmed on a second draw ~2 weeks later before it changes your plan.

Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.

Start with my labs →

Frequently asked questions

What's the difference between hs-CRP and regular CRP?

They measure the same protein but at different sensitivities. Standard CRP is used to track active infection or autoimmune disease, where values are often high. High-sensitivity CRP (hs-CRP) detects the low concentrations relevant to long-term cardiovascular risk. If your goal is cardiovascular risk, you want the hs-CRP assay specifically.

My hs-CRP was high once — should I be worried?

Not necessarily. A single high value, especially above 10 mg/L, usually reflects a temporary cause like a recent infection, injury, or intense workout. The meaningful signal is a *persistently* elevated hs-CRP measured when you're well. Retest in about two weeks before drawing conclusions.

Can I lower my hs-CRP?

Often, yes — by addressing the underlying source. Stopping smoking, losing visceral fat, improving metabolic health, treating gum disease, and increasing physical activity all tend to lower it. Statins also lower hs-CRP. Any plan should be individualized with your clinician, since the right lever depends on why yours is elevated.

Does a normal hs-CRP mean my heart is fine?

No single marker clears you. A low hs-CRP is reassuring for the inflammatory component of risk, but cholesterol (LDL/ApoB), blood pressure, glucose, family history, and lifestyle all matter. hs-CRP is designed to *add* to a risk assessment, not replace one.

Do I need to fast for an hs-CRP test?

Fasting is generally not required for hs-CRP itself. However, it's often drawn together with a lipid panel and glucose, which may call for fasting — follow the instructions for the full order. Most importantly, avoid testing during or right after an illness or injury.

References

All citations verified against PubMed / publisher of record (see note below for this page's verification date).

1.Pearson TA, Mensah GA, Alexander RW, et al. (2003). Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 107(3):499-511. — Source for the < 1.0 / 1.0–3.0 / > 3.0 mg/L cardiovascular risk bands and the > 10 mg/L retest guidance.PubMed →DOI →
2.Ridker PM, Danielson E, Fonseca FAH, et al. (JUPITER Study Group). (2008). Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. 359(21):2195-2207. — JUPITER: people with LDL < 130 mg/dL but elevated hs-CRP benefited from statin therapy — basis for the 'actionable residual risk' framing.PubMed →DOI →
3.Ridker PM, Everett BM, Thuren T, et al. (CANTOS Trial Group). (2017). Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine. 377(12):1119-1131. — CANTOS: lowering inflammation without changing cholesterol reduced cardiovascular events — evidence inflammation itself contributes to risk.PubMed →DOI →
4.Ridker PM. (2003). Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention. Circulation. 107(3):363-369. — Framework for hs-CRP as a marker that adds information beyond the standard lipid panel.PubMed →DOI →

hs-CRP thresholds are for cardiovascular risk assessment in people without acute illness; laboratories may report in mg/L or mg/dL, so check units. Every link opens the PubMed abstract or publisher's DOI landing page in a new tab. All citations verified vs PubMed / publisher of record 2026-07-18.

By Steve Pinedo

Co-founder, Phi Longevity

Last updated: 2026-07-18

Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →

High cholesterol labs

The lipid pattern hs-CRP adds risk on top of.

ApoB

The causal-particle count behind cardiovascular risk.

LDL cholesterol

The primary lipid target hs-CRP complements.